✦ LIBER ✦

Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non–Small-Cell Lung Cancer, A Phase II Trial

✍ Scribed by Ezra E.W. Cohen; Janakiraman Subramanian; Feng Gao; Livia Szeto; Mark Kozloff; Leonardo Faoro; Theodore Karrison; Ravi Salgia; Ramaswamy Govindan; Everett E. Vokes

Book ID: 113544788
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 336 KB
Volume: 13
Category: Article
ISSN: 1525-7304
DOI: 10.1016/j.cllc.2011.10.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

130 POSTER Phase II trial of Sequenced B

130 POSTER Phase II trial of Sequenced Bevacizumab and Erlotinib with Bevacizumab and Chemotherapy for 1st Line Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC)

✍ E. Cohen; R. Govindan; M. Kozloff; A. Mauer; P. Hoffman; T. Karrison; J. Stein; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 73 KB

9135 Erlotinib as maintenance therapy af

9135 Erlotinib as maintenance therapy after platinun-based chemotherapy in advanced non-small-cell lung cancer (NSCLC): a phase II trial

✍ Cobo-Dols, M.; Barneto-Aranda, I.; Bernabé-Caro, R.; Valdivia, J.; Fernandez-Can 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Randomized Phase II Trial of Erlotinib o

Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non-Small-Cell Lung Cancer and a Performance Status of 2

✍ Lilenbaum, R.; Axelrod, R.; Thomas, S.; Dowlati, A.; Seigel, L.; Albert, D.; Wit 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 205 KB

Efficacy of bevacizumab plus erlotinib v

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial

✍ Roy S Herbst; Rafat Ansari; Frederique Bustin; Patrick Flynn; Lowell Hart; Grego 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 338 KB

977 Phase I/II trial evaluating blockade

977 Phase I/II trial evaluating blockade of tumour blood supply and tumour cell proliferation with combined bevacizumab and erlotinib HCl as targeted cancer therapy in patients with recurrent non-small cell lung cancer

✍ R.S. Herbst; E. Mininberg; T. Henderson; E. Kim; W.K. Hong; R. Mass; W. Novotny; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Phase III Trial: Concurrent Chemotherapy

Phase III Trial: Concurrent Chemotherapy and Radiation Therapy: A New Standard of Care for Stage III Non–Small-Cell Lung Cancer

✍ CIG Media Group 📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 73 KB